Linear scleroderma 'en coup de sabre' associated with facial atrophy in a patient seropositive for Borrelia burgdorferi: A true case of molecular mimicry?

Pediatric Allergy and Immunology

Volumn 15, Issue 6, 2004, Pages 570-572

  Salpietro, D C ^a   Merlino, M V ^a   Bruglia, S ^a   Guarneri, F ^a   Vaccaro, M ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BORRELIA BURGDORFERI; CASE REPORT; CHRONIC INFLAMMATION; CLINICAL FEATURE; CROSS REACTION; DISEASE ASSOCIATION; FACE DISORDER; FACIAL ATROPHY; FACIAL NERVE PARALYSIS; FEMALE; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; LETTER; LICHEN SCLEROSUS ET ATROPHICUS; MOLECULAR MECHANICS; MOLECULAR MIMICRY; PATHOGENESIS; PRIORITY JOURNAL; PTOSIS; SCHOOL CHILD; SCLERODERMA; SKIN DISEASE;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; CHILD; CYTOKINES; FACIAL HEMIATROPHY; FEMALE; HUMANS; IMMUNOBLOTTING; LYME DISEASE; MOLECULAR MIMICRY; SCLERODERMA, LOCALIZED; SEROLOGIC TESTS;

EID: 11144264037     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2004.00189.x     Document Type: Letter

References (18)

1. OLDSTONE MBA. Molecular mimicry and immune-mediated diseases. FASEB J 1998: 12: 1255-65.
2. WUCHERPFENNIG KW. Structural basis of molecular mimicry. J Autoimmun 2001: 16: 293-302.
3. ABERER E, NEUMANN R, STANEK J. Is localized scleroderma a Borrelia infection? Lancet (letter) 1985: 2: 278.
4. SCHEMPP C, BOCKLAGE H, LANGE R, KOLMEL HW, ORFANOS CE, GOLLNICK H. Further evidence for Borrelia burgdorferi infection in morphoea and liehen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 1993: 100: 717-20.
5. SIGAL LH. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol 1997: 15: 63-92.
6. ALONSO-LLAMAZARES J, PERSING DH, ANDA P, GIBSON LE, RUTLEDGE BJ, IGLESIAS L. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review. Acta Derm Venereol 1997: 77: 299-304.
7. WEIDE B, WALZ T, GARBE C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol 2000: 142: 636-44.
8. OZKAN S, ATABEY N, FETIL E, ERKIZAN V, GUNES AT. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol 2000: 39: 278-83.
9. WEIDE B, SCHITTEK B, KLYSCZ T, et al. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol 2000: 143: 780-5.
10. HERCOGOVA J. Borrelia burgdorferi: a protagonist in Lyme disease, a bystander in morphoea? J Eur Acad Dermatol Venereol 2002: 16: 98-9.
11. VACCARO M, GUARNERI F, BORGIA F, CANNAVO SP, BENVENGA S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid 2002: 12: 1147-8.
12. VACCARO M, GUARNERI F, GUARNERI C, BORGIA F, CANNAVO SP. Sweet's syndrome and erythema nodosum after Klebsiella pneumoniae cystitis. Acta Derm Venereol 2003: 83: 290-1.
13. HASEGAWA M, SATO S, NAGAOKA T, FUJIMOTO M, TAKEHARA K. Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma. Dermatology 2003: 207: 141-7.
14. IHN H, FUJIMOTO M, SATO S, et al. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. J Am Acad Dermatol 1994: 31: 591-5.
15. YAMANE K, IHN H, KUBO M, et al. Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma. J Am Acad Dermatol 2000: 42: 64-9.
16. YSSEL H, SHANAFELT MC, SODERBERG C, SCHNEIDER PV, ANZOLA J, PELTZ G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 1991: 174: 593-601.
17. AKIN E, AVERSA J, STEERE AC. Expression of adhesion molecules in synovia of patients with treatment-resistant lyme arthritis. Infect Immun 2001: 69: 1774-80.
18. TROLLMO C, MEYER AL, STEERE AC, HAOER DA, HUBER BT. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. J Immunol 2001: 166: 5286-91.